Cite
HARVARD Citation
Rahalkar, H. et al. (2022). Biosimilar development and review process in the BRICS-TM countries: Proposal for a standardized model to improve regulatory performance. Expert review of clinical pharmacology. 15 (2), pp. 215-236. [Online].